Antabus 400 mg, Brausetabletten - 50 Tablette(n) Swissmedic Key 15104015 Registration Holder Teva Pharma AG Name Antabus 400 mg, Brausetabletten Date of registration 01.12.1949 Introduction of Sequence 01.12.1949 ATC-Classification Disulfiram (N07BB01) Revision date 01.04.2005 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 15. Show package size 50 Tablette(n) Index Therapeuticus (Swissmedic) 15.02. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 23.04 Limitation Yes Limitation text
Deductible 10 % Consumer price 41.45 Feedback FB Daily cost GTIN 7680151040150 Medication Code Synthetika Pharmacode 183644 Disponibility
Composition disulfiramum 400.0 mg, polysorbatum 20, maydis amylum, povidonum K 30, acidum tartaricum, natrii hydrogenocarbonas corresp. natrium 13.14 mg, talcum, silica colloidalis anhydrica, magnesii stearas, cellulosum microcristallinum, pro compresso. Packungsbestandteile Galenic Form Effervescent tablets Active Agent Dose Disulfirame 400 mg
BAG: Active Agent Dose Disulfirame 400 mg
Inactive agents Dose Tartaric Acid Cellulosum Microcristallinum Magnesii Stearas Maydis Amylum Sodium Hydrogen Carbonate Polysorbatum 20 Povidonum K 30 Pro Compresso Silica Colloidalis Anhydrica Talcum
Source Data was imported : 17.11.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
